Benchling (YC S12) Is Modernizing Software For Biotech Labs
techcrunch.com
techcrunch.com
Yet, I don't see much evidence of growth. Looks like 'play money' for investors.
"The crowded market of backup software has many viable open source alternatives. Besides, many tools have been developed or are being developed by established companies."
I am open to sharing ideas offline - and rich experiences on why the ones that tried have not succeeded so far.
Good comment anyway.